74 related articles for article (PubMed ID: 7326104)
21. Soluble intercellular adhesion molecule-1 and natural killer cell activity in gastric cancer patients.
Kaihara A; Iwagaki H; Gouchi A; Hizuta A; Isozaki H; Takakura N; Tanaka N
Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):283-300. PubMed ID: 9730008
[TBL] [Abstract][Full Text] [Related]
22. Suppression of natural killer cell activity by serum derived from head and neck cancer patients.
Kumazawa H; Minamino M; Yukawa N; Hess M
Cancer Detect Prev; 1995; 19(6):494-502. PubMed ID: 8925518
[TBL] [Abstract][Full Text] [Related]
23. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
24. Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood.
Auer IO; Ziemer E; Sommer H
Clin Exp Immunol; 1980 Oct; 42(1):41-9. PubMed ID: 7460390
[TBL] [Abstract][Full Text] [Related]
25. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.
Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK
Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837
[TBL] [Abstract][Full Text] [Related]
26. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
[TBL] [Abstract][Full Text] [Related]
27. Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial.
Arai S; Meagher R; Swearingen M; Myint H; Rich E; Martinson J; Klingemann H
Cytotherapy; 2008; 10(6):625-32. PubMed ID: 18836917
[TBL] [Abstract][Full Text] [Related]
28. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
Webb BJ; Bochan MR; Montel A; Padilla LM; Brahmi Z
Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757
[TBL] [Abstract][Full Text] [Related]
29. Functional analysis of peripheral blood lymphocytes from healthy volunteers.
Donnerstag B; Oltrogge JB; Henzel K; Rüenauver A; Baum RP
J Clin Lab Immunol; 1993; 40(2):91-5. PubMed ID: 7932632
[TBL] [Abstract][Full Text] [Related]
30. [Effect of C-reactive protein on natural killer activity].
Shibuya M; Saijo N; Shimizu E; Taniguchi T; Takizawa T; Fujioka H; Hoshi A
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2341-6. PubMed ID: 6639096
[TBL] [Abstract][Full Text] [Related]
31. Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer.
Konjević G; Spuzić I
Neoplasma; 1993; 40(2):81-5. PubMed ID: 8350959
[TBL] [Abstract][Full Text] [Related]
32. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption.
Laso FJ; Madruga JI; Girón JA; López A; Ciudad J; San Miguel JF; Alvarez-Mon M; Orfao A
Hepatology; 1997 May; 25(5):1096-100. PubMed ID: 9141423
[TBL] [Abstract][Full Text] [Related]
33. Natural killer cytolytic activity is associated with the expression of killer cell immunoglobulin-like receptors on peripheral lymphocytes in human.
Kogure T; Mantani N; Sakai S; Shimada Y; Tamura J; Terasawa K
Mediators Inflamm; 2003 Apr; 12(2):117-21. PubMed ID: 12775362
[TBL] [Abstract][Full Text] [Related]
34. Natural killer cells in the host response to melanoma.
Kornstein MJ; Stewart R; Elder DE
Cancer Res; 1987 Mar; 47(5):1411-2. PubMed ID: 3815344
[TBL] [Abstract][Full Text] [Related]
35. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
[TBL] [Abstract][Full Text] [Related]
36. A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases.
Shibatomi K; Ida H; Yamasaki S; Nakashima T; Origuchi T; Kawakami A; Migita K; Kawabe Y; Tsujihata M; Anderson P; Eguchi K
Arthritis Rheum; 2001 Apr; 44(4):884-92. PubMed ID: 11315928
[TBL] [Abstract][Full Text] [Related]
37. The influence of general anesthesia and surgery on cell-mediated cytotoxicity and interferon production.
Møller-Larsen F; Møller-Larsen A; Haahr S
J Clin Lab Immunol; 1983 Oct; 12(2):69-75. PubMed ID: 6196485
[TBL] [Abstract][Full Text] [Related]
38. Killing activity of human umbilical cord blood-derived TCRValpha24(+) NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells.
Hagihara M; Gansuvd B; Ueda Y; Tsuchiya T; Masui A; Tazume K; Inoue H; Kato S; Hotta T
Cancer Immunol Immunother; 2002 Mar; 51(1):1-8. PubMed ID: 11845254
[TBL] [Abstract][Full Text] [Related]
39. Administration of R24 monoclonal antibody and low-dose interleukin 2 for malignant melanoma.
Soiffer RJ; Chapman PB; Murray C; Williams L; Unger P; Collins H; Houghton AN; Ritz J
Clin Cancer Res; 1997 Jan; 3(1):17-24. PubMed ID: 9815532
[TBL] [Abstract][Full Text] [Related]
40. [Characteristics of the changes in the natural killer activity of peripheral blood lymphocytes during pregnancy].
Shalakhova OV; Malygin AM; Fel' VIa
Tsitologiia; 1987 Aug; 29(8):942-7. PubMed ID: 3686670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]